Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) Gross Profit (2017 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Gross Profit for 9 consecutive years, with $2006.0 as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 11.44% to $2006.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3806.0 through Dec 2025, down 42.33% year-over-year, with the annual reading at $3806.0 for FY2025, 42.33% down from the prior year.
  • Gross Profit for Q4 2025 was $2006.0 at Creative Medical Technology Holdings, up from $1800.0 in the prior quarter.
  • The five-year high for Gross Profit was $39000.0 in Q3 2022, with the low at $1800.0 in Q4 2023.
  • Average Gross Profit over 5 years is $9643.3, with a median of $5150.0 recorded in 2021.
  • The sharpest move saw Gross Profit surged 550.0% in 2022, then crashed 90.77% in 2023.
  • Over 5 years, Gross Profit stood at $28305.0 in 2021, then plummeted by 54.43% to $12900.0 in 2022, then crashed by 86.05% to $1800.0 in 2023, then changed by 0.0% to $1800.0 in 2024, then grew by 11.44% to $2006.0 in 2025.
  • According to Business Quant data, Gross Profit over the past three periods came in at $2006.0, $1800.0, and $1800.0 for Q4 2025, Q1 2025, and Q4 2024 respectively.